Digest Network Come funziona
Network
/
Società
On
Non verificato

OncoNano Medicine, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

5 comunicati stampa

Guarda tutti i comunicati
17/04/2026
Eventi
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
OncoNano to Present New Preclinical Data at AACR 2026 Highlighting Effective Tumor Delivery Enabled by ON-BOARD™ Platform
Fonte
OncoNano Medicine, Inc.
Emittente
Business Wire
1.00
0
06/01/2026
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Mercato del lavoro
OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate
Fonte
OncoNano Medicine, Inc.
Emittente
Business Wire
1.00
0
17/11/2025
Oncologia
Salute
Tecnica
Tecnologie Varie
Farmaceutica
Biotecnologia
Mercato del lavoro
OncoNano Announces Appointment of Brent Sorrells as Chief Operating Officer
Fonte
OncoNano Medicine, Inc.
Emittente
Business Wire
1.00
0
27/10/2025
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
OncoNano Medicine Presents First-in-Human Data Demonstrating Safety and Early Signs of Clinical Activity of ONM-501, a Dual-Acting STING Agonist, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Fonte
OncoNano Medicine, Inc.
Emittente
Business Wire
1.00
0
15/10/2025
Biotecnologia
Salute
Oncologia
Medicina - Varie
Eventi
Industria
OncoNano Medicine Announces Presentation at AACR-NIC-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Fonte
OncoNano Medicine, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0